KKR agreed to acquire Integer Holdings, a cardiac-rhythm and neuromodulation components manufacturer, for $5.7 billion in cash. The transaction values Integer at approximately $150 per share, a 20% premium to the 30-day volume-weighted average. The deal is structured as a full take-private with no rollover equity and financing committed through KKR's North America Fund XIII and its co-investment vehicles.
Integer supplies batteries, capacitors, and enclosures to Medtronic, Abbott, and Boston Scientific—the invisible infrastructure layer of implantable cardiac devices and neurostimulators. Revenue for the twelve months ending June 2024 was $1.68 billion, with 82% derived from OEM contracts spanning multi-year supply agreements. EBITDA margins hovered near 22%, compressed by input-cost inflation and a backlog of product-qualification cycles for next-generation pulse generators. KKR's thesis centers on margin recapture through procurement consolidation and automation of the Tijuana and Reynosa manufacturing footprint, where Integer operates nine facilities employing roughly 7,200 people.
This marks KKR's third medical-device platform in four years, following the $13 billion take-private of Syneos Health's device trials unit in 2023 and the $2.1 billion acquisition of Parexel's medical-device CRO in 2021. The firm now controls $41 billion in healthcare assets under management, the highest allocation since it spun out its captive insurance arms in 2020. What matters is the regulatory tailwind: the FDA's 510(k) backlog cleared 19% faster in Q2 2024 than the prior year, accelerating product launches and therefore OEM demand for Integer's components. Medicare reimbursement rates for cardiac resynchronization therapy devices rose 3.2% in January 2024, the first meaningful increase since 2019, which lifts unit economics across the supply chain.
The $5.7 billion valuation implies an EV/EBITDA multiple near 15.4x, expensive for a Tier 2 supplier but defensible given Integer's sole-source status on certain battery chemistries and the $840 million in contracted backlog through 2027. KKR will inherit $1.2 billion in net debt, manageable against the $370 million in trailing free cash flow. The leverage here is operational, not financial: every 100 basis points of margin expansion adds roughly $17 million to EBITDA, and KKR has historically delivered 220 to 310 basis points in the first eighteen months post-close through labor optimization and supplier renegotiation.
Allocators should watch for follow-on bolt-ons in the six to nine months after close, particularly in specialty coatings or miniaturized antenna assemblies where Integer lacks scale. KKR filed Hart-Scott-Rodino paperwork on July 30; clearance typically lands within 75 days absent second requests. Financing documentation disclosed a $1.9 billion bridge commitment from JPMorgan and Goldman Sachs, suggesting roughly $3.8 billion in equity and the remainder in term loans priced near SOFR plus 375 basis points. If the FDA's device-review cycle continues to compress, Integer's backlog converts faster, pulling forward the first dividend recapitalization and shortening KKR's hold period to four years instead of the customary six.
The deal closes in Q4 2024, and Integer's Plano headquarters will remain operational with no immediate headcount reduction planned. The real tell will be KKR's appointment to the board: if it seats a former Medtronic or Abbott supply-chain executive, the strategy is customer capture; if it's a manufacturing-operations specialist, the bet is margin.
The takeaway
KKR's $5.7B Integer buy consolidates the cardiac-device supply chain and bets on FDA throughput acceleration driving faster OEM conversions through 2027.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori Press · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.